

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 7.86328398 |
| 2 | maintenance of protein location in nucleus (GO:0051457) | 6.96118647 |
| 3 | regulation of response to osmotic stress (GO:0047484) | 6.73603414 |
| 4 | somite rostral/caudal axis specification (GO:0032525) | 6.65491488 |
| 5 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 6.59072472 |
| 6 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 6.29034718 |
| 7 | negative regulation of epidermis development (GO:0045683) | 6.25755450 |
| 8 | negative regulation of telomerase activity (GO:0051974) | 5.88989257 |
| 9 | protein localization to kinetochore (GO:0034501) | 5.87535500 |
| 10 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 5.80199163 |
| 11 | muscle organ morphogenesis (GO:0048644) | 5.74323329 |
| 12 | regulation of MHC class I biosynthetic process (GO:0045343) | 5.64317791 |
| 13 | regulation of telomere maintenance via telomerase (GO:0032210) | 5.63433869 |
| 14 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 5.59693497 |
| 15 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 5.59377265 |
| 16 | histone H4-K12 acetylation (GO:0043983) | 5.47049651 |
| 17 | histone H4-K8 acetylation (GO:0043982) | 5.40685715 |
| 18 | histone H4-K5 acetylation (GO:0043981) | 5.40685715 |
| 19 | rRNA transcription (GO:0009303) | 5.22280219 |
| 20 | notochord development (GO:0030903) | 5.17728887 |
| 21 | cytidine deamination (GO:0009972) | 5.12693915 |
| 22 | cytidine metabolic process (GO:0046087) | 5.12693915 |
| 23 | cytidine catabolic process (GO:0006216) | 5.12693915 |
| 24 | hormone catabolic process (GO:0042447) | 4.92982241 |
| 25 | negative regulation of epidermal cell differentiation (GO:0045605) | 4.87300347 |
| 26 | regulation of cilium movement (GO:0003352) | 4.72684775 |
| 27 | phenol-containing compound catabolic process (GO:0019336) | 4.72524564 |
| 28 | barbed-end actin filament capping (GO:0051016) | 4.69805744 |
| 29 | response to dietary excess (GO:0002021) | 4.69201628 |
| 30 | mitotic sister chromatid segregation (GO:0000070) | 4.68597076 |
| 31 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.68578288 |
| 32 | heterochromatin organization (GO:0070828) | 4.60248871 |
| 33 | protein maturation by protein folding (GO:0022417) | 4.50547744 |
| 34 | rRNA methylation (GO:0031167) | 4.47451585 |
| 35 | nucleoside transmembrane transport (GO:1901642) | 4.46624929 |
| 36 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 4.45486921 |
| 37 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 4.45186423 |
| 38 | primitive streak formation (GO:0090009) | 4.31173490 |
| 39 | interferon-gamma production (GO:0032609) | 4.27413131 |
| 40 | protein localization to chromosome, centromeric region (GO:0071459) | 4.18745501 |
| 41 | negative regulation of telomere maintenance (GO:0032205) | 4.13573662 |
| 42 | regulation of translation in response to stress (GO:0043555) | 4.12905376 |
| 43 | rRNA modification (GO:0000154) | 4.08676397 |
| 44 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 4.04845879 |
| 45 | DNA replication-dependent nucleosome organization (GO:0034723) | 4.04553926 |
| 46 | DNA replication-dependent nucleosome assembly (GO:0006335) | 4.04553926 |
| 47 | chromatin assembly (GO:0031497) | 3.99008028 |
| 48 | cellular modified amino acid catabolic process (GO:0042219) | 3.97232430 |
| 49 | maintenance of protein localization in organelle (GO:0072595) | 3.97186749 |
| 50 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.93048597 |
| 51 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 3.89937273 |
| 52 | histone H4-K16 acetylation (GO:0043984) | 3.87163428 |
| 53 | pinocytosis (GO:0006907) | 3.83676224 |
| 54 | epoxygenase P450 pathway (GO:0019373) | 3.82645641 |
| 55 | sister chromatid segregation (GO:0000819) | 3.80991990 |
| 56 | intestinal epithelial cell development (GO:0060576) | 3.77493718 |
| 57 | extracellular fibril organization (GO:0043206) | 3.76222176 |
| 58 | arachidonic acid secretion (GO:0050482) | 3.73367272 |
| 59 | icosanoid secretion (GO:0032309) | 3.73367272 |
| 60 | bone trabecula formation (GO:0060346) | 3.73229214 |
| 61 | positive regulation of protein deacetylation (GO:0090312) | 3.72210812 |
| 62 | nuclear pore complex assembly (GO:0051292) | 3.71127937 |
| 63 | mitochondrion distribution (GO:0048311) | 3.69540153 |
| 64 | vitamin A metabolic process (GO:0006776) | 3.68074732 |
| 65 | cardiovascular system development (GO:0072358) | 3.67057901 |
| 66 | fibril organization (GO:0097435) | 3.64932909 |
| 67 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.62856368 |
| 68 | retinoic acid receptor signaling pathway (GO:0048384) | 3.62514674 |
| 69 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.61903241 |
| 70 | virion attachment to host cell (GO:0019062) | 3.61475719 |
| 71 | adhesion of symbiont to host cell (GO:0044650) | 3.61475719 |
| 72 | DNA replication checkpoint (GO:0000076) | 3.58895322 |
| 73 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 3.58340568 |
| 74 | regulation of telomerase activity (GO:0051972) | 3.56374623 |
| 75 | protein localization to endosome (GO:0036010) | 3.55891120 |
| 76 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 3.55419757 |
| 77 | regulation of gene silencing by RNA (GO:0060966) | 3.54659355 |
| 78 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.54659355 |
| 79 | regulation of gene silencing by miRNA (GO:0060964) | 3.54659355 |
| 80 | GDP-mannose metabolic process (GO:0019673) | 3.53254216 |
| 81 | melanin biosynthetic process (GO:0042438) | 3.45758758 |
| 82 | cullin deneddylation (GO:0010388) | 3.42470540 |
| 83 | phagocytosis, recognition (GO:0006910) | 3.42382536 |
| 84 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.41313957 |
| 85 | nucleoside transport (GO:0015858) | 3.39875336 |
| 86 | trophectodermal cell differentiation (GO:0001829) | 3.39605567 |
| 87 | proline transport (GO:0015824) | 3.36918149 |
| 88 | maternal placenta development (GO:0001893) | 3.35405898 |
| 89 | transcription from mitochondrial promoter (GO:0006390) | 3.31253920 |
| 90 | pre-miRNA processing (GO:0031054) | 3.30434604 |
| 91 | microtubule severing (GO:0051013) | 3.29872727 |
| 92 | tachykinin receptor signaling pathway (GO:0007217) | 3.27874917 |
| 93 | regulation of telomere maintenance (GO:0032204) | 3.27874379 |
| 94 | positive regulation of histone deacetylation (GO:0031065) | 3.27401270 |
| 95 | type B pancreatic cell proliferation (GO:0044342) | 3.27141813 |
| 96 | RNA stabilization (GO:0043489) | 3.25124611 |
| 97 | mRNA stabilization (GO:0048255) | 3.25124611 |
| 98 | membrane raft organization (GO:0031579) | 3.25029568 |
| 99 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.23102682 |
| 100 | nuclear pore organization (GO:0006999) | 3.22474262 |
| 101 | COPI coating of Golgi vesicle (GO:0048205) | 3.21945298 |
| 102 | Golgi transport vesicle coating (GO:0048200) | 3.21945298 |
| 103 | omega-hydroxylase P450 pathway (GO:0097267) | 3.21264351 |
| 104 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 3.18968754 |
| 105 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 3.18636070 |
| 106 | cellular response to zinc ion (GO:0071294) | 3.14272105 |
| 107 | adhesion of symbiont to host (GO:0044406) | 3.13721252 |
| 108 | L-ascorbic acid metabolic process (GO:0019852) | 3.13716700 |
| 109 | hypotonic response (GO:0006971) | 3.12143918 |
| 110 | pyrimidine-containing compound salvage (GO:0008655) | 3.10653377 |
| 111 | pyrimidine nucleoside salvage (GO:0043097) | 3.10653377 |
| 112 | transepithelial transport (GO:0070633) | 3.09899805 |
| 113 | cyclooxygenase pathway (GO:0019371) | 3.09811152 |
| 114 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.09111990 |
| 115 | negative regulation of interleukin-2 production (GO:0032703) | 3.09021704 |
| 116 | primary alcohol catabolic process (GO:0034310) | 3.07039371 |
| 117 | regulation of hippo signaling (GO:0035330) | 3.06811480 |
| 118 | positive regulation of macrophage cytokine production (GO:0060907) | 3.06755342 |
| 119 | ribosome biogenesis (GO:0042254) | 3.05860263 |
| 120 | mature B cell differentiation involved in immune response (GO:0002313) | 3.05263998 |
| 121 | skin morphogenesis (GO:0043589) | 3.05132634 |
| 122 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.03731458 |
| 123 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 3.02376048 |
| 124 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.95766684 |
| 125 | melanin metabolic process (GO:0006582) | 2.95487288 |
| 126 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.95453116 |
| 127 | regulation of vitamin metabolic process (GO:0030656) | 2.92619238 |
| 128 | proteasome assembly (GO:0043248) | 2.87023692 |
| 129 | hyaluronan catabolic process (GO:0030214) | 2.86614863 |
| 130 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.83247432 |
| 131 | cellular response to arsenic-containing substance (GO:0071243) | 2.78720169 |
| 132 | natural killer cell mediated immunity (GO:0002228) | 2.77653046 |
| 133 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.77653046 |
| 134 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.77539250 |
| 135 | cellular response to interferon-alpha (GO:0035457) | 2.73410716 |
| 136 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.73359879 |
| 137 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.68603852 |
| 138 | UV protection (GO:0009650) | 2.68083254 |
| 139 | pentose-phosphate shunt (GO:0006098) | 2.67788195 |
| 140 | GTP biosynthetic process (GO:0006183) | 2.65381406 |
| 141 | mitotic nuclear envelope reassembly (GO:0007084) | 2.62085807 |
| 142 | nuclear envelope reassembly (GO:0031468) | 2.62085807 |
| 143 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.61852553 |
| 144 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.61294039 |
| 145 | nucleoside salvage (GO:0043174) | 2.59600078 |
| 146 | NIK/NF-kappaB signaling (GO:0038061) | 2.58151066 |
| 147 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.57485884 |
| 148 | response to progesterone (GO:0032570) | 2.56061312 |
| 149 | protein retention in ER lumen (GO:0006621) | 2.53992215 |
| 150 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.53369102 |
| 151 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.52961350 |
| 152 | amino sugar catabolic process (GO:0046348) | 2.50842279 |
| 153 | low-density lipoprotein particle clearance (GO:0034383) | 2.48092959 |
| 154 | response to type I interferon (GO:0034340) | 2.48091972 |
| 155 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.47700678 |
| 156 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.47560312 |
| 157 | UTP biosynthetic process (GO:0006228) | 2.46854713 |
| 158 | regulation of necrotic cell death (GO:0010939) | 2.44953473 |
| 159 | response to thyroid hormone (GO:0097066) | 2.41699735 |
| 160 | cell adhesion mediated by integrin (GO:0033627) | 2.39206974 |
| 161 | secondary metabolite biosynthetic process (GO:0044550) | 2.38950750 |
| 162 | cellular response to type I interferon (GO:0071357) | 2.38438143 |
| 163 | type I interferon signaling pathway (GO:0060337) | 2.38438143 |
| 164 | AMP metabolic process (GO:0046033) | 2.38172465 |
| 165 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.38002459 |
| 166 | glucose catabolic process (GO:0006007) | 2.37809457 |
| 167 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.37689171 |
| 168 | response to copper ion (GO:0046688) | 2.36910017 |
| 169 | negative regulation of JAK-STAT cascade (GO:0046426) | 2.36800828 |
| 170 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.36516004 |
| 171 | muscle cell migration (GO:0014812) | 2.35915436 |
| 172 | desmosome organization (GO:0002934) | 2.35447254 |
| 173 | purine nucleotide salvage (GO:0032261) | 2.35205855 |
| 174 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 2.34995871 |
| 175 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.33592875 |
| 176 | regulation of early endosome to late endosome transport (GO:2000641) | 2.32442853 |
| 177 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.32006716 |
| 178 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.31093548 |
| 179 | stress fiber assembly (GO:0043149) | 2.30805325 |
| 180 | cellular response to cadmium ion (GO:0071276) | 2.28917682 |
| 181 | cellular copper ion homeostasis (GO:0006878) | 2.28734498 |
| 182 | nucleotide salvage (GO:0043173) | 2.27952986 |
| 183 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.26379249 |
| 184 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.26162426 |
| 185 | keratan sulfate catabolic process (GO:0042340) | 2.26161080 |
| 186 | regulation of chronic inflammatory response (GO:0002676) | 2.25136444 |
| 187 | regulation of immunoglobulin secretion (GO:0051023) | 2.24871562 |
| 188 | negative regulation of monooxygenase activity (GO:0032769) | 2.24048837 |
| 189 | lipoxygenase pathway (GO:0019372) | 2.20891901 |
| 190 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.20492198 |
| 191 | NADPH regeneration (GO:0006740) | 2.19860519 |
| 192 | daunorubicin metabolic process (GO:0044597) | 12.1861294 |
| 193 | polyketide metabolic process (GO:0030638) | 12.1861294 |
| 194 | doxorubicin metabolic process (GO:0044598) | 12.1861294 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 6.84423129 |
| 2 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 6.84423129 |
| 3 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 6.84423129 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.69747601 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.41225786 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.92538667 |
| 7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.46316834 |
| 8 | * NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 3.27911783 |
| 9 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.27278775 |
| 10 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 3.12920724 |
| 11 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 3.04396252 |
| 12 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.97629189 |
| 13 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.92708294 |
| 14 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.79163113 |
| 15 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.79079828 |
| 16 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.77621501 |
| 17 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.68878190 |
| 18 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.63998784 |
| 19 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.35777898 |
| 20 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.18263126 |
| 21 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.14609080 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.10571320 |
| 23 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.09933603 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.07297689 |
| 25 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 2.06956438 |
| 26 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.06491385 |
| 27 | * NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 2.01167392 |
| 28 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.01054001 |
| 29 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.98119307 |
| 30 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.95001797 |
| 31 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.94459712 |
| 32 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.92555501 |
| 33 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.92086682 |
| 34 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.91652253 |
| 35 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.84919402 |
| 36 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.84671057 |
| 37 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.84619316 |
| 38 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.83631266 |
| 39 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.82691366 |
| 40 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.81297220 |
| 41 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.79686451 |
| 42 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.75474080 |
| 43 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.73213947 |
| 44 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.73133048 |
| 45 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.68044425 |
| 46 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.66944017 |
| 47 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.65744951 |
| 48 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.62594886 |
| 49 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.62197101 |
| 50 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.61284512 |
| 51 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.56473052 |
| 52 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.56114731 |
| 53 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53896793 |
| 54 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.52627387 |
| 55 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.51915021 |
| 56 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.51817843 |
| 57 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.49646063 |
| 58 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.46008667 |
| 59 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.45169062 |
| 60 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.45044383 |
| 61 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.44237586 |
| 62 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.44117287 |
| 63 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.43733377 |
| 64 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.43073825 |
| 65 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.43011322 |
| 66 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.43011322 |
| 67 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.40867483 |
| 68 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.40020426 |
| 69 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.39874801 |
| 70 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.36071702 |
| 71 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.35588153 |
| 72 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.35430734 |
| 73 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.34170441 |
| 74 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.32089951 |
| 75 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.31972528 |
| 76 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.31499242 |
| 77 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.30020766 |
| 78 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.29889449 |
| 79 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.29826831 |
| 80 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.29823705 |
| 81 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.29027617 |
| 82 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.28855412 |
| 83 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.28003412 |
| 84 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.27031168 |
| 85 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.25774815 |
| 86 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.25735214 |
| 87 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.24231928 |
| 88 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.22279974 |
| 89 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.21561533 |
| 90 | * E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.21387503 |
| 91 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.20918958 |
| 92 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.19302282 |
| 93 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19191504 |
| 94 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.19057365 |
| 95 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.17600735 |
| 96 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.16494305 |
| 97 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.16360374 |
| 98 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.16149733 |
| 99 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.13495235 |
| 100 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.13395457 |
| 101 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.13037391 |
| 102 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11998126 |
| 103 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.11691486 |
| 104 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11308787 |
| 105 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09947497 |
| 106 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.09621566 |
| 107 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09522013 |
| 108 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09295617 |
| 109 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.09128162 |
| 110 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.08649083 |
| 111 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.08011226 |
| 112 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.07782475 |
| 113 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.07574054 |
| 114 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.06882865 |
| 115 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.05506272 |
| 116 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.04723815 |
| 117 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.03689893 |
| 118 | MYC_22102868_ChIP-Seq_BL_Human | 1.03463035 |
| 119 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.03316445 |
| 120 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.02434009 |
| 121 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01907096 |
| 122 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.01887804 |
| 123 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00939011 |
| 124 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.00719635 |
| 125 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.00652615 |
| 126 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.98591907 |
| 127 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.97932901 |
| 128 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.96351380 |
| 129 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.96106378 |
| 130 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.96015385 |
| 131 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.95573201 |
| 132 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.95238902 |
| 133 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.95137249 |
| 134 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95060699 |
| 135 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.94917797 |
| 136 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.93743824 |
| 137 | * POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.91358567 |
| 138 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.89953110 |
| 139 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.88891349 |
| 140 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.87444812 |
| 141 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.85900818 |
| 142 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.84308407 |
| 143 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.83893928 |
| 144 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.83042930 |
| 145 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.83001399 |
| 146 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.82910252 |
| 147 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.81837981 |
| 148 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.79516570 |
| 149 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.79467302 |
| 150 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.78954265 |
| 151 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78723267 |
| 152 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.76965323 |
| 153 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.76091470 |
| 154 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.75272428 |
| 155 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.75167549 |
| 156 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.74074987 |
| 157 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.73814190 |
| 158 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.73723777 |
| 159 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.73168975 |
| 160 | KDM2B_26808549_Chip-Seq_K562_Human | 0.72987912 |
| 161 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.72832897 |
| 162 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.72697752 |
| 163 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.71468254 |
| 164 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.71394657 |
| 165 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.71150612 |
| 166 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.70230904 |
| 167 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.68081343 |
| 168 | * SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.67650443 |
| 169 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.67432092 |
| 170 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.67308489 |
| 171 | * STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.66256823 |
| 172 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.66106277 |
| 173 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.65683540 |
| 174 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.65501801 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 4.86961743 |
| 2 | MP0003011_delayed_dark_adaptation | 4.78915405 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 4.48644534 |
| 4 | MP0004264_abnormal_extraembryonic_tissu | 4.37074638 |
| 5 | MP0006292_abnormal_olfactory_placode | 4.13614332 |
| 6 | MP0004858_abnormal_nervous_system | 3.57179699 |
| 7 | MP0005058_abnormal_lysosome_morphology | 3.49546473 |
| 8 | MP0003890_abnormal_embryonic-extraembry | 3.49089105 |
| 9 | MP0008438_abnormal_cutaneous_collagen | 3.42836939 |
| 10 | MP0005499_abnormal_olfactory_system | 3.20166967 |
| 11 | MP0005394_taste/olfaction_phenotype | 3.20166967 |
| 12 | MP0003705_abnormal_hypodermis_morpholog | 3.12208119 |
| 13 | MP0002332_abnormal_exercise_endurance | 3.02584196 |
| 14 | MP0005075_abnormal_melanosome_morpholog | 3.01509462 |
| 15 | MP0005257_abnormal_intraocular_pressure | 2.82434028 |
| 16 | MP0003122_maternal_imprinting | 2.52608798 |
| 17 | MP0004957_abnormal_blastocyst_morpholog | 2.46102880 |
| 18 | MP0008057_abnormal_DNA_replication | 2.44911780 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.44638121 |
| 20 | MP0010352_gastrointestinal_tract_polyps | 2.44496693 |
| 21 | MP0009840_abnormal_foam_cell | 2.37284041 |
| 22 | MP0004510_myositis | 2.34540176 |
| 23 | MP0003279_aneurysm | 2.33175548 |
| 24 | MP0002653_abnormal_ependyma_morphology | 2.31998913 |
| 25 | MP0000678_abnormal_parathyroid_gland | 2.29565082 |
| 26 | MP0006035_abnormal_mitochondrial_morpho | 2.18306711 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 2.11487961 |
| 28 | MP0010234_abnormal_vibrissa_follicle | 2.05777078 |
| 29 | MP0003950_abnormal_plasma_membrane | 2.03155135 |
| 30 | MP0006054_spinal_hemorrhage | 2.02850136 |
| 31 | MP0005171_absent_coat_pigmentation | 1.99083146 |
| 32 | MP0010030_abnormal_orbit_morphology | 1.98423908 |
| 33 | MP0003453_abnormal_keratinocyte_physiol | 1.91267714 |
| 34 | MP0001542_abnormal_bone_strength | 1.88000738 |
| 35 | MP0003121_genomic_imprinting | 1.84238745 |
| 36 | MP0003303_peritoneal_inflammation | 1.83454372 |
| 37 | MP0005275_abnormal_skin_tensile | 1.82890900 |
| 38 | MP0008961_abnormal_basal_metabolism | 1.82762723 |
| 39 | MP0003075_altered_response_to | 1.80327974 |
| 40 | MP0003938_abnormal_ear_development | 1.74752769 |
| 41 | MP0005380_embryogenesis_phenotype | 1.73340554 |
| 42 | MP0001672_abnormal_embryogenesis/_devel | 1.73340554 |
| 43 | MP0002277_abnormal_respiratory_mucosa | 1.69768356 |
| 44 | MP0001849_ear_inflammation | 1.65943682 |
| 45 | MP0002088_abnormal_embryonic_growth/wei | 1.61219253 |
| 46 | MP0001293_anophthalmia | 1.60964583 |
| 47 | MP0006082_CNS_inflammation | 1.60461817 |
| 48 | MP0001958_emphysema | 1.60425952 |
| 49 | MP0002127_abnormal_cardiovascular_syste | 1.59749998 |
| 50 | MP0005165_increased_susceptibility_to | 1.59067945 |
| 51 | MP0003984_embryonic_growth_retardation | 1.58908757 |
| 52 | MP0003183_abnormal_peptide_metabolism | 1.56924241 |
| 53 | MP0001853_heart_inflammation | 1.55546260 |
| 54 | MP0000762_abnormal_tongue_morphology | 1.52108651 |
| 55 | MP0000049_abnormal_middle_ear | 1.49000598 |
| 56 | MP0002092_abnormal_eye_morphology | 1.44041485 |
| 57 | MP0002932_abnormal_joint_morphology | 1.44040685 |
| 58 | MP0003436_decreased_susceptibility_to | 1.42920043 |
| 59 | MP0000015_abnormal_ear_pigmentation | 1.42881044 |
| 60 | MP0002060_abnormal_skin_morphology | 1.42282711 |
| 61 | MP0005408_hypopigmentation | 1.39489669 |
| 62 | MP0005266_abnormal_metabolism | 1.32061966 |
| 63 | MP0000350_abnormal_cell_proliferation | 1.31154253 |
| 64 | MP0005501_abnormal_skin_physiology | 1.29612907 |
| 65 | MP0000372_irregular_coat_pigmentation | 1.28218384 |
| 66 | MP0004133_heterotaxia | 1.26597365 |
| 67 | MP0001533_abnormal_skeleton_physiology | 1.25810145 |
| 68 | MP0009333_abnormal_splenocyte_physiolog | 1.25319139 |
| 69 | MP0004947_skin_inflammation | 1.24531224 |
| 70 | MP0002086_abnormal_extraembryonic_tissu | 1.24492141 |
| 71 | MP0003300_gastrointestinal_ulcer | 1.24009419 |
| 72 | MP0002233_abnormal_nose_morphology | 1.22967623 |
| 73 | MP0008789_abnormal_olfactory_epithelium | 1.22834312 |
| 74 | MP0003091_abnormal_cell_migration | 1.22647502 |
| 75 | MP0005248_abnormal_Harderian_gland | 1.20814216 |
| 76 | MP0005451_abnormal_body_composition | 1.20678661 |
| 77 | MP0005166_decreased_susceptibility_to | 1.20279341 |
| 78 | MP0002085_abnormal_embryonic_tissue | 1.17458420 |
| 79 | MP0005508_abnormal_skeleton_morphology | 1.17123997 |
| 80 | MP0001835_abnormal_antigen_presentation | 1.16095884 |
| 81 | MP0008004_abnormal_stomach_pH | 1.15551510 |
| 82 | MP0001348_abnormal_lacrimal_gland | 1.15099119 |
| 83 | MP0009785_altered_susceptibility_to | 1.14975616 |
| 84 | MP0000371_diluted_coat_color | 1.12603206 |
| 85 | MP0010368_abnormal_lymphatic_system | 1.12480910 |
| 86 | MP0001216_abnormal_epidermal_layer | 1.12253023 |
| 87 | MP0003283_abnormal_digestive_organ | 1.11954289 |
| 88 | MP0000432_abnormal_head_morphology | 1.11854827 |
| 89 | MP0008260_abnormal_autophagy | 1.11187427 |
| 90 | MP0003755_abnormal_palate_morphology | 1.08534238 |
| 91 | MP0002970_abnormal_white_adipose | 1.07718509 |
| 92 | MP0009278_abnormal_bone_marrow | 1.07411393 |
| 93 | MP0000428_abnormal_craniofacial_morphol | 1.06414494 |
| 94 | MP0002114_abnormal_axial_skeleton | 1.05989776 |
| 95 | MP0005023_abnormal_wound_healing | 1.05283667 |
| 96 | MP0003724_increased_susceptibility_to | 1.03447718 |
| 97 | MP0000767_abnormal_smooth_muscle | 1.03441673 |
| 98 | MP0005670_abnormal_white_adipose | 1.02675964 |
| 99 | MP0002084_abnormal_developmental_patter | 1.02050564 |
| 100 | MP0004233_abnormal_muscle_weight | 1.01434334 |
| 101 | MP0002998_abnormal_bone_remodeling | 1.00552398 |
| 102 | MP0003119_abnormal_digestive_system | 0.99254043 |
| 103 | MP0003935_abnormal_craniofacial_develop | 0.99253818 |
| 104 | MP0005503_abnormal_tendon_morphology | 0.99055993 |
| 105 | MP0005397_hematopoietic_system_phenotyp | 0.99047159 |
| 106 | MP0001545_abnormal_hematopoietic_system | 0.99047159 |
| 107 | MP0003123_paternal_imprinting | 0.99033584 |
| 108 | MP0000750_abnormal_muscle_regeneration | 0.98880290 |
| 109 | MP0004043_abnormal_pH_regulation | 0.96419295 |
| 110 | MP0005390_skeleton_phenotype | 0.96227937 |
| 111 | MP0003077_abnormal_cell_cycle | 0.95981378 |
| 112 | MP0004197_abnormal_fetal_growth/weight/ | 0.94929139 |
| 113 | MP0008007_abnormal_cellular_replicative | 0.93526380 |
| 114 | MP0008469_abnormal_protein_level | 0.92090622 |
| 115 | MP0002249_abnormal_larynx_morphology | 0.91619524 |
| 116 | MP0005666_abnormal_adipose_tissue | 0.91126379 |
| 117 | MP0004381_abnormal_hair_follicle | 0.90571575 |
| 118 | MP0005623_abnormal_meninges_morphology | 0.89211883 |
| 119 | MP0004185_abnormal_adipocyte_glucose | 0.87848603 |
| 120 | MP0002166_altered_tumor_susceptibility | 0.87106973 |
| 121 | MP0005330_cardiomyopathy | 0.87035363 |
| 122 | MP0002419_abnormal_innate_immunity | 0.86361694 |
| 123 | MP0002132_abnormal_respiratory_system | 0.86145833 |
| 124 | MP0000733_abnormal_muscle_development | 0.86145768 |
| 125 | MP0005025_abnormal_response_to | 0.86089650 |
| 126 | MP0005000_abnormal_immune_tolerance | 0.85737295 |
| 127 | MP0008770_decreased_survivor_rate | 0.85260857 |
| 128 | MP0002925_abnormal_cardiovascular_devel | 0.85100987 |
| 129 | MP0000490_abnormal_crypts_of | 0.85048325 |
| 130 | MP0003137_abnormal_impulse_conducting | 0.84524878 |
| 131 | MP0002095_abnormal_skin_pigmentation | 0.84493624 |
| 132 | MP0002295_abnormal_pulmonary_circulatio | 0.84466524 |
| 133 | MP0004808_abnormal_hematopoietic_stem | 0.83695800 |
| 134 | MP0002396_abnormal_hematopoietic_system | 0.83364242 |
| 135 | MP0005391_vision/eye_phenotype | 0.82903003 |
| 136 | MP0005164_abnormal_response_to | 0.81280956 |
| 137 | MP0001845_abnormal_inflammatory_respons | 0.79126170 |
| 138 | MP0006036_abnormal_mitochondrial_physio | 0.78692099 |
| 139 | MP0000313_abnormal_cell_death | 0.78160993 |
| 140 | MP0002796_impaired_skin_barrier | 0.77959958 |
| 141 | MP0000749_muscle_degeneration | 0.77236874 |
| 142 | MP0002116_abnormal_craniofacial_bone | 0.76897319 |
| 143 | MP0003763_abnormal_thymus_physiology | 0.74718903 |
| 144 | MP0005375_adipose_tissue_phenotype | 0.74271491 |
| 145 | MP0002098_abnormal_vibrissa_morphology | 0.74135900 |
| 146 | MP0000627_abnormal_mammary_gland | 0.73942327 |
| 147 | MP0001881_abnormal_mammary_gland | 0.73324761 |
| 148 | MP0000604_amyloidosis | 0.72890357 |
| 149 | MP0005621_abnormal_cell_physiology | 0.72450011 |
| 150 | MP0000343_altered_response_to | 0.72187981 |
| 151 | MP0005595_abnormal_vascular_smooth | 0.71425177 |
| 152 | MP0005319_abnormal_enzyme/_coenzyme | 0.71172057 |
| 153 | MP0002452_abnormal_antigen_presenting | 0.70535085 |
| 154 | MP0004272_abnormal_basement_membrane | 0.70364820 |
| 155 | MP0010771_integument_phenotype | 0.69802144 |
| 156 | MP0001730_embryonic_growth_arrest | 0.69655190 |
| 157 | MP0001697_abnormal_embryo_size | 0.68196843 |
| 158 | MP0002080_prenatal_lethality | 0.68183198 |
| 159 | MP0002269_muscular_atrophy | 0.67534586 |
| 160 | MP0003315_abnormal_perineum_morphology | 0.67489227 |
| 161 | MP0001286_abnormal_eye_development | 0.66992792 |
| 162 | MP0003448_altered_tumor_morphology | 0.66858154 |
| 163 | MP0005197_abnormal_uvea_morphology | 0.66416750 |
| 164 | MP0003937_abnormal_limbs/digits/tail_de | 0.65992329 |
| 165 | MP0002751_abnormal_autonomic_nervous | 0.65787377 |
| 166 | MP0003566_abnormal_cell_adhesion | 0.65001686 |
| 167 | MP0003111_abnormal_nucleus_morphology | 0.63494102 |
| 168 | MP0002877_abnormal_melanocyte_morpholog | 0.62946714 |
| 169 | MP0008932_abnormal_embryonic_tissue | 0.62922261 |
| 170 | MP0000358_abnormal_cell_content/ | 0.62873418 |
| 171 | MP0003186_abnormal_redox_activity | 0.62456583 |
| 172 | MP0001243_abnormal_dermal_layer | 0.61248890 |
| 173 | MP0009703_decreased_birth_body | 0.60946744 |
| 174 | MP0004883_abnormal_blood_vessel | 0.60288000 |
| 175 | MP0009115_abnormal_fat_cell | 0.60134810 |
| 176 | MP0000858_altered_metastatic_potential | 0.58128214 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral microphthalmos (HP:0007633) | 7.55243957 |
| 2 | Hypochromic microcytic anemia (HP:0004840) | 6.04543069 |
| 3 | Hepatoblastoma (HP:0002884) | 5.44430512 |
| 4 | Multiple enchondromatosis (HP:0005701) | 5.28150626 |
| 5 | Abnormality of the lower motor neuron (HP:0002366) | 4.99600301 |
| 6 | Rib fusion (HP:0000902) | 4.88321725 |
| 7 | Premature rupture of membranes (HP:0001788) | 4.59318358 |
| 8 | Vertebral compression fractures (HP:0002953) | 4.32323081 |
| 9 | Ependymoma (HP:0002888) | 4.17804126 |
| 10 | Neoplasm of striated muscle (HP:0009728) | 3.73055783 |
| 11 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.60403347 |
| 12 | Axonal loss (HP:0003447) | 3.57070993 |
| 13 | Fused cervical vertebrae (HP:0002949) | 3.52881500 |
| 14 | Rhabdomyosarcoma (HP:0002859) | 3.52464713 |
| 15 | Partial duplication of thumb phalanx (HP:0009944) | 3.51094835 |
| 16 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.49893693 |
| 17 | Testicular atrophy (HP:0000029) | 3.49621736 |
| 18 | Protrusio acetabuli (HP:0003179) | 3.49612270 |
| 19 | Rectovaginal fistula (HP:0000143) | 3.46561782 |
| 20 | Rectal fistula (HP:0100590) | 3.46561782 |
| 21 | Hypoplasia of the fovea (HP:0007750) | 3.45204458 |
| 22 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.45204458 |
| 23 | Dysostosis multiplex (HP:0000943) | 3.42451514 |
| 24 | Nuclear cataract (HP:0100018) | 3.32919788 |
| 25 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.31048684 |
| 26 | Embryonal renal neoplasm (HP:0011794) | 3.28836276 |
| 27 | Osteolytic defects of the hand bones (HP:0009699) | 3.28231834 |
| 28 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.28231834 |
| 29 | Prolonged neonatal jaundice (HP:0006579) | 3.16354899 |
| 30 | Vaginal fistula (HP:0004320) | 3.15531224 |
| 31 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.15144900 |
| 32 | Partial duplication of the phalanx of hand (HP:0009999) | 3.11663054 |
| 33 | Abnormality of the salivary glands (HP:0010286) | 3.10308958 |
| 34 | Loss of speech (HP:0002371) | 3.08636276 |
| 35 | Intestinal fistula (HP:0100819) | 3.06395741 |
| 36 | Trismus (HP:0000211) | 3.05308409 |
| 37 | Follicular hyperkeratosis (HP:0007502) | 3.00732627 |
| 38 | Bifid tongue (HP:0010297) | 2.96820003 |
| 39 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.96573376 |
| 40 | Abnormality of the astrocytes (HP:0100707) | 2.96525448 |
| 41 | Astrocytoma (HP:0009592) | 2.96525448 |
| 42 | Short humerus (HP:0005792) | 2.95679344 |
| 43 | Abnormal cartilage morphology (HP:0002763) | 2.93363859 |
| 44 | Anomalous pulmonary venous return (HP:0010772) | 2.87133310 |
| 45 | Ragged-red muscle fibers (HP:0003200) | 2.85265948 |
| 46 | Amyotrophic lateral sclerosis (HP:0007354) | 2.83086740 |
| 47 | Spinal rigidity (HP:0003306) | 2.83086132 |
| 48 | Horizontal nystagmus (HP:0000666) | 2.78912767 |
| 49 | Chromsome breakage (HP:0040012) | 2.75517956 |
| 50 | Cervical subluxation (HP:0003308) | 2.72697851 |
| 51 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.71435524 |
| 52 | Short nail (HP:0001799) | 2.70785632 |
| 53 | Abnormal lung lobation (HP:0002101) | 2.70156195 |
| 54 | Ankle contracture (HP:0006466) | 2.64011905 |
| 55 | Vacuolated lymphocytes (HP:0001922) | 2.60757783 |
| 56 | Elbow flexion contracture (HP:0002987) | 2.60017113 |
| 57 | Reduced antithrombin III activity (HP:0001976) | 2.59123812 |
| 58 | Large earlobe (HP:0009748) | 2.58121098 |
| 59 | Abnormality of the fovea (HP:0000493) | 2.57026594 |
| 60 | Preauricular skin tag (HP:0000384) | 2.54903256 |
| 61 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.54565264 |
| 62 | Increased connective tissue (HP:0009025) | 2.54544819 |
| 63 | Patchy hypopigmentation of hair (HP:0011365) | 2.54510411 |
| 64 | White forelock (HP:0002211) | 2.54336101 |
| 65 | Hypochromic anemia (HP:0001931) | 2.52247091 |
| 66 | Shawl scrotum (HP:0000049) | 2.50868419 |
| 67 | Generalized amyotrophy (HP:0003700) | 2.49749496 |
| 68 | Abnormality of the pulmonary veins (HP:0011718) | 2.46249849 |
| 69 | Generalized hypotonia (HP:0001290) | 2.44559019 |
| 70 | Periauricular skin pits (HP:0100277) | 2.44418590 |
| 71 | Preauricular pit (HP:0004467) | 2.44418590 |
| 72 | Abnormality of the Achilles tendon (HP:0005109) | 2.41677628 |
| 73 | Spondylolisthesis (HP:0003302) | 2.38671067 |
| 74 | Esophageal neoplasm (HP:0100751) | 2.35311280 |
| 75 | Neoplasm of head and neck (HP:0012288) | 2.35311280 |
| 76 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.34781229 |
| 77 | Nasolacrimal duct obstruction (HP:0000579) | 2.34291768 |
| 78 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.33499458 |
| 79 | Progressive muscle weakness (HP:0003323) | 2.32924747 |
| 80 | Distal lower limb muscle weakness (HP:0009053) | 2.32102984 |
| 81 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.31402810 |
| 82 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.31402810 |
| 83 | Abnormality of glycolipid metabolism (HP:0010969) | 2.31402810 |
| 84 | Sensory axonal neuropathy (HP:0003390) | 2.31061009 |
| 85 | Hand muscle atrophy (HP:0009130) | 2.30241562 |
| 86 | Abnormality of the musculature of the hand (HP:0001421) | 2.30212173 |
| 87 | Systemic lupus erythematosus (HP:0002725) | 2.29982652 |
| 88 | Supernumerary spleens (HP:0009799) | 2.26791707 |
| 89 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.26442358 |
| 90 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.26442358 |
| 91 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.26442358 |
| 92 | Neoplasm of the heart (HP:0100544) | 2.25894958 |
| 93 | Skin tags (HP:0010609) | 2.23164751 |
| 94 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.23017707 |
| 95 | Difficulty running (HP:0009046) | 2.22571678 |
| 96 | Hyperventilation (HP:0002883) | 2.22365536 |
| 97 | Tetraplegia (HP:0002445) | 2.22262248 |
| 98 | Tongue fasciculations (HP:0001308) | 2.22242924 |
| 99 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.21518859 |
| 100 | Impulsivity (HP:0100710) | 2.20119262 |
| 101 | Upper motor neuron abnormality (HP:0002127) | 2.19896528 |
| 102 | Abnormality of chromosome segregation (HP:0002916) | 2.19428267 |
| 103 | Mucopolysacchariduria (HP:0008155) | 2.19019782 |
| 104 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.19019782 |
| 105 | Hepatosplenomegaly (HP:0001433) | 2.17653347 |
| 106 | Short 5th finger (HP:0009237) | 2.17569100 |
| 107 | Alopecia of scalp (HP:0002293) | 2.17389278 |
| 108 | Villous atrophy (HP:0011473) | 2.15232216 |
| 109 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.15232216 |
| 110 | Increased cerebral lipofuscin (HP:0011813) | 2.15130929 |
| 111 | Glioma (HP:0009733) | 2.14454598 |
| 112 | Pseudobulbar signs (HP:0002200) | 2.13752085 |
| 113 | Multiple lipomas (HP:0001012) | 2.11939635 |
| 114 | Achilles tendon contracture (HP:0001771) | 2.11607924 |
| 115 | Cheilitis (HP:0100825) | 2.11607384 |
| 116 | Meckel diverticulum (HP:0002245) | 2.08711176 |
| 117 | Erythema (HP:0010783) | 2.08399013 |
| 118 | Rough bone trabeculation (HP:0100670) | 2.08298975 |
| 119 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.07672210 |
| 120 | Abnormality of the pubic bones (HP:0003172) | 2.06383257 |
| 121 | Joint stiffness (HP:0001387) | 2.05852922 |
| 122 | Progressive neurologic deterioration (HP:0002344) | 2.05823017 |
| 123 | Acanthosis nigricans (HP:0000956) | 2.05398307 |
| 124 | Hypopigmentation of the fundus (HP:0007894) | 2.02637965 |
| 125 | Muscle fibrillation (HP:0010546) | 2.02317057 |
| 126 | Malignant neoplasm of the central nervous system (HP:0100836) | 2.01988971 |
| 127 | Hypoplastic scapulae (HP:0000882) | 2.01636715 |
| 128 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 2.01636715 |
| 129 | Natal tooth (HP:0000695) | 2.01209589 |
| 130 | Glucose intolerance (HP:0000833) | 2.01207035 |
| 131 | Glossoptosis (HP:0000162) | 2.01053263 |
| 132 | Malnutrition (HP:0004395) | 1.99537406 |
| 133 | Supernumerary nipples (HP:0002558) | 1.99312668 |
| 134 | Wormian bones (HP:0002645) | 1.98771712 |
| 135 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.98639975 |
| 136 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 1.98459077 |
| 137 | Abnormality of the nasal mucosa (HP:0000433) | 1.98321010 |
| 138 | Vertebral fusion (HP:0002948) | 1.98209270 |
| 139 | Interstitial pulmonary disease (HP:0006530) | 1.97878452 |
| 140 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.96852242 |
| 141 | Abnormality of the umbilical cord (HP:0010881) | 1.96811978 |
| 142 | Upper limb muscle weakness (HP:0003484) | 1.96520537 |
| 143 | Fasciculations (HP:0002380) | 1.96012773 |
| 144 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.95586475 |
| 145 | Abnormality of the ileum (HP:0001549) | 1.94928292 |
| 146 | Peritonitis (HP:0002586) | 1.94885335 |
| 147 | Bone cyst (HP:0012062) | 1.93786371 |
| 148 | Abnormality of the intrinsic pathway (HP:0010989) | 1.93679047 |
| 149 | Fragile skin (HP:0001030) | 1.92768965 |
| 150 | Skin pits (HP:0100276) | 1.92062595 |
| 151 | Renal duplication (HP:0000075) | 1.91180994 |
| 152 | Multifactorial inheritance (HP:0001426) | 1.91136479 |
| 153 | Hyperparathyroidism (HP:0000843) | 1.89722022 |
| 154 | Atrophic scars (HP:0001075) | 1.88732408 |
| 155 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.88649745 |
| 156 | Distal upper limb amyotrophy (HP:0007149) | 1.87488802 |
| 157 | Upper limb amyotrophy (HP:0009129) | 1.87488802 |
| 158 | Genu recurvatum (HP:0002816) | 1.84530661 |
| 159 | Bulbar palsy (HP:0001283) | 1.84043756 |
| 160 | Renal Fanconi syndrome (HP:0001994) | 1.83683229 |
| 161 | J-shaped sella turcica (HP:0002680) | 1.83342658 |
| 162 | Blue sclerae (HP:0000592) | 1.82923444 |
| 163 | Aortic aneurysm (HP:0004942) | 1.82072760 |
| 164 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.81715276 |
| 165 | Cardiovascular calcification (HP:0011915) | 1.79671566 |
| 166 | Biconcave vertebral bodies (HP:0004586) | 1.79598604 |
| 167 | Sparse eyelashes (HP:0000653) | 1.79168382 |
| 168 | Ocular albinism (HP:0001107) | 1.78447550 |
| 169 | Spinal cord compression (HP:0002176) | 1.78258489 |
| 170 | Myocardial infarction (HP:0001658) | 1.77994083 |
| 171 | Conjunctival hamartoma (HP:0100780) | 1.77391147 |
| 172 | Aortic regurgitation (HP:0001659) | 1.76233146 |
| 173 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.74026885 |
| 174 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.72689392 |
| 175 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.72215103 |
| 176 | Entropion (HP:0000621) | 1.71181805 |
| 177 | Cerebral inclusion bodies (HP:0100314) | 1.69932113 |
| 178 | Amyloidosis (HP:0011034) | 1.69152526 |
| 179 | Increased IgM level (HP:0003496) | 1.68201030 |
| 180 | Abnormal trabecular bone morphology (HP:0100671) | 1.68192361 |
| 181 | Abnormality of the frontal sinuses (HP:0002687) | 1.66911984 |
| 182 | Long toe (HP:0010511) | 1.66506398 |
| 183 | Microretrognathia (HP:0000308) | 1.65662053 |
| 184 | Polygenic inheritance (HP:0010982) | 1.62940644 |
| 185 | Tetraparesis (HP:0002273) | 1.62253616 |
| 186 | Broad face (HP:0000283) | 1.62173686 |
| 187 | Hypertriglyceridemia (HP:0002155) | 1.61190973 |
| 188 | Neurofibrillary tangles (HP:0002185) | 1.60340011 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 8.09007635 |
| 2 | NME2 | 5.66842316 |
| 3 | GRK5 | 5.52957266 |
| 4 | ERN1 | 4.96352872 |
| 5 | GRK6 | 4.38932262 |
| 6 | TESK1 | 3.61097703 |
| 7 | IRAK3 | 3.46955422 |
| 8 | ADRBK2 | 3.32035633 |
| 9 | GRK1 | 3.27093435 |
| 10 | TGFBR2 | 2.87736284 |
| 11 | CSF1R | 2.79738536 |
| 12 | TYRO3 | 2.71631154 |
| 13 | MAP3K3 | 2.69099717 |
| 14 | ARAF | 2.67085742 |
| 15 | PIM2 | 2.59872325 |
| 16 | GRK7 | 2.56354055 |
| 17 | TTK | 2.42116466 |
| 18 | MATK | 2.41552570 |
| 19 | MAPK7 | 2.34554819 |
| 20 | MOS | 2.32042792 |
| 21 | STK10 | 2.25605384 |
| 22 | MYLK | 2.13974021 |
| 23 | LIMK1 | 2.13235085 |
| 24 | VRK2 | 2.05791015 |
| 25 | TBK1 | 1.96299389 |
| 26 | ABL2 | 1.92416743 |
| 27 | WNK1 | 1.88018088 |
| 28 | NTRK1 | 1.62809113 |
| 29 | MAP3K13 | 1.62637589 |
| 30 | EPHA2 | 1.61388661 |
| 31 | PRKG2 | 1.58807332 |
| 32 | MST1R | 1.54699525 |
| 33 | BUB1 | 1.53931820 |
| 34 | CDK7 | 1.48276925 |
| 35 | SMG1 | 1.45257468 |
| 36 | CAMK4 | 1.43721141 |
| 37 | MAP2K3 | 1.38024714 |
| 38 | ILK | 1.37919686 |
| 39 | SCYL2 | 1.37371619 |
| 40 | PAK4 | 1.36633955 |
| 41 | MARK3 | 1.35199704 |
| 42 | PBK | 1.30560011 |
| 43 | MARK2 | 1.26796794 |
| 44 | ADRBK1 | 1.19262135 |
| 45 | HIPK2 | 1.16265925 |
| 46 | MAP3K14 | 1.15325992 |
| 47 | CHEK2 | 1.08106238 |
| 48 | AKT3 | 1.06833906 |
| 49 | DAPK3 | 1.03136647 |
| 50 | FGFR3 | 1.03021171 |
| 51 | MAP3K10 | 0.97104932 |
| 52 | MAP2K4 | 0.93941767 |
| 53 | LATS2 | 0.93029531 |
| 54 | BRAF | 0.91535589 |
| 55 | PLK1 | 0.90825517 |
| 56 | MAP3K11 | 0.89570504 |
| 57 | TTN | 0.88861335 |
| 58 | STK16 | 0.85618759 |
| 59 | CSK | 0.85529137 |
| 60 | CSNK1G3 | 0.82917433 |
| 61 | BCKDK | 0.81945687 |
| 62 | ALK | 0.80845110 |
| 63 | CSNK1A1L | 0.79739466 |
| 64 | MAP3K12 | 0.79334333 |
| 65 | TRPM7 | 0.77025697 |
| 66 | PDK2 | 0.76692508 |
| 67 | DAPK1 | 0.73099952 |
| 68 | MAP3K1 | 0.72612696 |
| 69 | MAP2K6 | 0.72025206 |
| 70 | JAK3 | 0.71859780 |
| 71 | TYK2 | 0.70552707 |
| 72 | AKT2 | 0.70143156 |
| 73 | EIF2AK1 | 0.67495229 |
| 74 | PRKD3 | 0.67094210 |
| 75 | CDC42BPA | 0.66942482 |
| 76 | MAP3K9 | 0.66701980 |
| 77 | LMTK2 | 0.63702844 |
| 78 | KDR | 0.63495224 |
| 79 | MAP3K7 | 0.63411700 |
| 80 | MAPK12 | 0.61978487 |
| 81 | PDGFRA | 0.61097215 |
| 82 | IRAK2 | 0.60578329 |
| 83 | CHEK1 | 0.60388358 |
| 84 | EIF2AK2 | 0.57976341 |
| 85 | IKBKE | 0.54438750 |
| 86 | DDR2 | 0.54166076 |
| 87 | PTK2 | 0.52063947 |
| 88 | PRKCI | 0.48779426 |
| 89 | RIPK1 | 0.48500114 |
| 90 | MTOR | 0.48351817 |
| 91 | BMX | 0.48148510 |
| 92 | MAP3K8 | 0.47924837 |
| 93 | MAP3K6 | 0.47031146 |
| 94 | NEK9 | 0.46979745 |
| 95 | BRSK1 | 0.46672999 |
| 96 | CAMKK2 | 0.45817676 |
| 97 | IGF1R | 0.42977948 |
| 98 | RPS6KA2 | 0.41629919 |
| 99 | MAPKAPK3 | 0.40969492 |
| 100 | RPS6KB2 | 0.40882695 |
| 101 | CAMK2G | 0.40246691 |
| 102 | KIT | 0.39786392 |
| 103 | CCNB1 | 0.39223961 |
| 104 | PINK1 | 0.38853924 |
| 105 | WEE1 | 0.38264540 |
| 106 | IKBKB | 0.38257228 |
| 107 | MELK | 0.38151581 |
| 108 | MAPKAPK5 | 0.36491357 |
| 109 | TLK1 | 0.35777758 |
| 110 | CSNK1G2 | 0.35736525 |
| 111 | CDK2 | 0.35548417 |
| 112 | PRKCD | 0.34728410 |
| 113 | AURKA | 0.34687462 |
| 114 | PAK1 | 0.34044699 |
| 115 | BMPR2 | 0.33432845 |
| 116 | ERBB2 | 0.33393015 |
| 117 | CDK8 | 0.33361467 |
| 118 | MAPK11 | 0.32388057 |
| 119 | EEF2K | 0.32241166 |
| 120 | PRKD2 | 0.30116852 |
| 121 | TESK2 | 0.27952661 |
| 122 | INSR | 0.27630450 |
| 123 | MST4 | 0.27085745 |
| 124 | PRPF4B | 0.26612107 |
| 125 | NEK2 | 0.26607334 |
| 126 | MAPK10 | 0.24624239 |
| 127 | CSNK1E | 0.23564025 |
| 128 | ITK | 0.23499202 |
| 129 | STK38 | 0.23384382 |
| 130 | CDK4 | 0.20664771 |
| 131 | AURKB | 0.20529472 |
| 132 | GSK3A | 0.20186166 |
| 133 | DYRK2 | 0.19554476 |
| 134 | TAOK2 | 0.19502725 |
| 135 | PAK3 | 0.19414192 |
| 136 | MAPK1 | 0.19213896 |
| 137 | ATM | 0.18572987 |
| 138 | PRKACG | 0.17259313 |
| 139 | DYRK1B | 0.15931736 |
| 140 | TAOK1 | 0.15747078 |
| 141 | GSK3B | 0.15349909 |
| 142 | MAPK4 | 0.15304716 |
| 143 | CDK15 | 0.15193054 |
| 144 | CDC7 | 0.14660117 |
| 145 | CDK1 | 0.14327763 |
| 146 | MET | 0.13994048 |
| 147 | BLK | 0.13933711 |
| 148 | CHUK | 0.12900436 |
| 149 | MAPK14 | 0.12766047 |
| 150 | CDK11A | 0.12743602 |
| 151 | SIK1 | 0.12156658 |
| 152 | CDK18 | 0.11630344 |
| 153 | TRIB3 | 0.11382447 |
| 154 | NEK1 | 0.11234326 |
| 155 | PAK6 | 0.11164578 |
| 156 | PRKACB | 0.09806578 |
| 157 | PRKACA | 0.09359593 |
| 158 | MAPKAPK2 | 0.09276954 |
| 159 | PAK2 | 0.08765288 |
| 160 | PRKAA1 | 0.08396480 |
| 161 | ERBB4 | 0.08080475 |
| 162 | ICK | 0.07813947 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 6.88573466 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 6.54001318 |
| 3 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 4.23455626 |
| 4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.82201440 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 2.98155225 |
| 6 | Galactose metabolism_Homo sapiens_hsa00052 | 2.94032805 |
| 7 | Lysosome_Homo sapiens_hsa04142 | 2.79146536 |
| 8 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.59435867 |
| 9 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.24673212 |
| 10 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.21167540 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.14768926 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.10294208 |
| 13 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.90335282 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.88759267 |
| 15 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.80751953 |
| 16 | * Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.80353033 |
| 17 | Thyroid cancer_Homo sapiens_hsa05216 | 1.74751131 |
| 18 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.73754547 |
| 19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.71936830 |
| 20 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.66651414 |
| 21 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.63334487 |
| 22 | Shigellosis_Homo sapiens_hsa05131 | 1.45583000 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.45567296 |
| 24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.45460574 |
| 25 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.44694231 |
| 26 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.43607095 |
| 27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.43470927 |
| 28 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.42571433 |
| 29 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.40650236 |
| 30 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.38477045 |
| 31 | Malaria_Homo sapiens_hsa05144 | 1.37994904 |
| 32 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.33911141 |
| 33 | RNA transport_Homo sapiens_hsa03013 | 1.30731647 |
| 34 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.30488608 |
| 35 | Pertussis_Homo sapiens_hsa05133 | 1.28474235 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.26266838 |
| 37 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.20243310 |
| 38 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.14345309 |
| 39 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.12041378 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.11114853 |
| 41 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.10525372 |
| 42 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.10052270 |
| 43 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.09978621 |
| 44 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.08585926 |
| 45 | Asthma_Homo sapiens_hsa05310 | 1.07297851 |
| 46 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.07257929 |
| 47 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.04167615 |
| 48 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.03479097 |
| 49 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.02325700 |
| 50 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.00637187 |
| 51 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.00533198 |
| 52 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.00088968 |
| 53 | Allograft rejection_Homo sapiens_hsa05330 | 0.98473553 |
| 54 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.97645961 |
| 55 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.97034575 |
| 56 | Prion diseases_Homo sapiens_hsa05020 | 0.96023061 |
| 57 | Influenza A_Homo sapiens_hsa05164 | 0.95831023 |
| 58 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.95785925 |
| 59 | Phagosome_Homo sapiens_hsa04145 | 0.94158514 |
| 60 | Tuberculosis_Homo sapiens_hsa05152 | 0.92865682 |
| 61 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.92732630 |
| 62 | Hepatitis B_Homo sapiens_hsa05161 | 0.92442704 |
| 63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.92426651 |
| 64 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.92055374 |
| 65 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.90609422 |
| 66 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.90518028 |
| 67 | Ribosome_Homo sapiens_hsa03010 | 0.88623639 |
| 68 | Bladder cancer_Homo sapiens_hsa05219 | 0.88394567 |
| 69 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.85693630 |
| 70 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.85216387 |
| 71 | Pathways in cancer_Homo sapiens_hsa05200 | 0.85202900 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 0.84319180 |
| 73 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.84292364 |
| 74 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.83548882 |
| 75 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.83373667 |
| 76 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.80979582 |
| 77 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.79936846 |
| 78 | Viral myocarditis_Homo sapiens_hsa05416 | 0.79594505 |
| 79 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.79473542 |
| 80 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.79091689 |
| 81 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.78669427 |
| 82 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.78552612 |
| 83 | Legionellosis_Homo sapiens_hsa05134 | 0.77845451 |
| 84 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.77525686 |
| 85 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.77040293 |
| 86 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.75807699 |
| 87 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.74977941 |
| 88 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.73912997 |
| 89 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.72911790 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.72508799 |
| 91 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.72067689 |
| 92 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.71384845 |
| 93 | Cell cycle_Homo sapiens_hsa04110 | 0.70886989 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69174913 |
| 95 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.69127398 |
| 96 | Leishmaniasis_Homo sapiens_hsa05140 | 0.68272325 |
| 97 | Sulfur relay system_Homo sapiens_hsa04122 | 0.66726222 |
| 98 | Measles_Homo sapiens_hsa05162 | 0.65091704 |
| 99 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63547096 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.62984552 |
| 101 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.62130879 |
| 102 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.61955511 |
| 103 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.61255619 |
| 104 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.59741446 |
| 105 | RNA degradation_Homo sapiens_hsa03018 | 0.59564623 |
| 106 | Alzheimers disease_Homo sapiens_hsa05010 | 0.58977773 |
| 107 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.58319991 |
| 108 | RNA polymerase_Homo sapiens_hsa03020 | 0.57738509 |
| 109 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.57496992 |
| 110 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.56813242 |
| 111 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.54989851 |
| 112 | Apoptosis_Homo sapiens_hsa04210 | 0.53727492 |
| 113 | DNA replication_Homo sapiens_hsa03030 | 0.53057648 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51394165 |
| 115 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51332328 |
| 116 | Endocytosis_Homo sapiens_hsa04144 | 0.51219372 |
| 117 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.50814593 |
| 118 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.50641693 |
| 119 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.50094491 |
| 120 | Homologous recombination_Homo sapiens_hsa03440 | 0.49502719 |
| 121 | Mismatch repair_Homo sapiens_hsa03430 | 0.47236799 |
| 122 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.47102831 |
| 123 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.46869724 |
| 124 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.45647132 |
| 125 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42833982 |
| 126 | Adherens junction_Homo sapiens_hsa04520 | 0.42285164 |
| 127 | Amoebiasis_Homo sapiens_hsa05146 | 0.42120487 |
| 128 | Carbon metabolism_Homo sapiens_hsa01200 | 0.41740019 |
| 129 | Parkinsons disease_Homo sapiens_hsa05012 | 0.41730788 |
| 130 | Tight junction_Homo sapiens_hsa04530 | 0.41503418 |
| 131 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.41002373 |
| 132 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.40521459 |
| 133 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.40234296 |
| 134 | Mineral absorption_Homo sapiens_hsa04978 | 0.40088737 |
| 135 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.38963518 |
| 136 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.37911403 |
| 137 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37438733 |
| 138 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.37364197 |
| 139 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.37104737 |
| 140 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.36197798 |
| 141 | Prostate cancer_Homo sapiens_hsa05215 | 0.35869887 |
| 142 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35000440 |
| 143 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.34768865 |
| 144 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.33649614 |
| 145 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.33153289 |
| 146 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.33008126 |
| 147 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.32543409 |
| 148 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.31162129 |
| 149 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.30922179 |
| 150 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.30836153 |
| 151 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29205450 |
| 152 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.26142871 |
| 153 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.25641402 |
| 154 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.24394605 |
| 155 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.24220279 |
| 156 | Base excision repair_Homo sapiens_hsa03410 | 0.24201622 |
| 157 | Taste transduction_Homo sapiens_hsa04742 | 0.20512615 |
| 158 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.20512534 |
| 159 | Spliceosome_Homo sapiens_hsa03040 | 0.19023656 |
| 160 | Focal adhesion_Homo sapiens_hsa04510 | 0.18708774 |
| 161 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.16438066 |
| 162 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.15028663 |
| 163 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.14916880 |
| 164 | HTLV-I infection_Homo sapiens_hsa05166 | 0.14750082 |

